Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/25/24 16:18 | 11/21/24 | IRD | Health | Drug | Pharmaceutical Preparations | Yerxa Benjamin R | MI | DO | P | 1 | P | 10 | 0.9834 | 0 | 10 | 3 | 343 | D | ||||||||||||||
11/19/24 16:08 | 11/15/24 | IRD | Health | Drug | Pharmaceutical Preparations | Magrath George | MI | O | CEO | 3 | P.m | 159 | 1.22 | 0 | 130 | 36 | 493 | D | ||||||||||||||
5/24/24 16:07 | 5/22/24 | OCUP | Health | Drug | Pharmaceutical Preparations | Jayagopal Ashwath | MI | O | Chief Sc | 1 | P | 6 | 1.77 | 0 | 4 | 5 | 79 | D | ||||||||||||||
3/25/24 16:44 | 3/21/24 | OCUP | Health | Drug | Pharmaceutical Preparations | Schachle Joseph K | MI | O | COO | 1 | P | 4 | 2.05 | 0 | 2 | 2 | D | |||||||||||||||
3/25/24 16:40 | 3/21/24 | OCUP | Health | Drug | Pharmaceutical Preparations | Jhaveri Nirav S. | MI | O | CFO | 1 | P | 21 | 2.10 | 0 | 10 | 7 | 150 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |